Response of 1α,25-Dihydroxyvitamin D3to Hypocalcemia in Human Subjects
- 31 August 1978
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 299 (9), 437-441
- https://doi.org/10.1056/nejm197808312990902
Abstract
We determined the response of 1α,25-dihydroxyvitamin D3 after mithramycin-induced hypocalcemia in eight subjects with polyostotic Paget's disease of bone. Thirty-six hours after infusion of mithramycin (25 μg per kilogram), the average calcium declined from 9.9±0.14 (S.E.M.) to 8.0±0.19 mg per deciliter (P3 rose from 98±12 to 332±61 pM (P3 and changes in parathyroid hormone (correlation coefficient, r = +0.91) and phosphate (r=-0.96). The relatively rapid response of 1α,25-dihydroxyvitamin D3 to hypocalcemia occurs with a time course consistent with regulation by parathyroid hormone and phosphate. (N Engl J Med 299:437–441, 1978)This publication has 36 references indexed in Scilit:
- Basic and Clinical Concepts Related to Vitamin D Metabolism and ActionNew England Journal of Medicine, 1977
- Nephrogenous Cyclic Adenosine Monophosphate as a Parathyroid Function TestJCI Insight, 1977
- A Cheap Oral Therapy for Paget's Disease of BoneAustralian and New Zealand Journal of Medicine, 1977
- Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.JCI Insight, 1976
- Metabolism and Mechanism of Action of Vitamin DAnnual Review of Biochemistry, 1976
- Mithramycin effects on calcium, phosphorus and parathyroid hormone in osseous Paget??s diseaseThe American Journal of the Medical Sciences, 1975
- Radioreceptor Assay for 1α,25-Dihydroxyvitamin D 3Science, 1974
- Treatment of Paget's Disease of Bone with MithramycinBMJ, 1971
- Effects of parathyroid hormone on plasma and urinary adenosine 3′,5′-monophosphate in manJCI Insight, 1970
- Pseudohypoparathyroidism: defective excretion of 3′,5′-AMP in response to parathyroid hormoneJCI Insight, 1969